Constipation Clinical Trial
— ACCESSOfficial title:
A Phase IIb, Double-blind, Randomised, Placebo-controlled, Multi-centre, Dose-finding Efficacy and Safety Study of a Range of Doses of A3309 in Patients With Chronic Idiopathic Constipation
Verified date | October 2010 |
Source | Albireo |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Food and Drug Administration |
Study type | Interventional |
The purpose of this trial is to determine the efficacy and safety of A3309 administered to patients with chronic idiopathic constipation.
Status | Completed |
Enrollment | 190 |
Est. completion date | October 2010 |
Est. primary completion date | October 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 20 Years to 80 Years |
Eligibility |
Inclusion Criteria: - Patient meets protocol specified criteria for constipation - Patient has successfully completed study requirements with no clinically relevant findings for physical exam, ECG, laboratory tests and colonoscopy as applicable Exclusion Criteria: - Medical history or medical condition that would not make the patient a good candidate for the study or limit the patient´s ability to complete the study - Patient reports loose stools - Patient has IBS with pain/discomfort as predominant symptom - Patient needs medications prohibited as specified in the protocol |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Albireo Investigative Site | Albuquerque | New Mexico |
United States | Albireo Investigative Site | Anaheim | California |
United States | Albireo Investigative Site | Anderson | South Carolina |
United States | Albireo Investigative Site | Annapolis | Maryland |
United States | Albireo Investigative Site | Baltimore | Maryland |
United States | Albireo Investigative Site | Boynton Beach | Florida |
United States | Albireo Investigative Site | Chandler | Arizona |
United States | Albireo Investigative Site | Charlotte | North Carolina |
United States | Albireo Investigative Site | Chattanooga | Tennessee |
United States | Albireo Investigative Site | Chesterfield | Michigan |
United States | Albireo Investigative Site | Cincinnati | Ohio |
United States | Albireo Investigative Site | Cincinnati | Ohio |
United States | Albireo Investigative Site | Clive | Iowa |
United States | Albireo Investigative Site | Colorado Springs | Colorado |
United States | Albireo Investigative Site | Davenport | Iowa |
United States | Albireo Investigative Site | Dayton | Ohio |
United States | Albireo Investigative Site | El Paso | Texas |
United States | Albireo Investigative Site | Encinitas | California |
United States | Albireo Investigative Site | Great Neck | New York |
United States | Albireo Investigative Site | Greensboro | North Carolina |
United States | Albireo Investigative Site | Harrisburg | North Carolina |
United States | Albireo Investigative Site | Henderson | Nevada |
United States | Albireo Investigative Site | Hollywood | Maryland |
United States | Albireo Investigative Site | Huntsville | Alabama |
United States | Albireo Investigative Site | Inverness | Florida |
United States | Albireo Investigative Site | Kingsport | Tennessee |
United States | Albireo Investigative Site | La Crosse | Wisconsin |
United States | Albireo Investigative Site | Levittown | Pennsylvania |
United States | Albireo Investigative Site | Longview | Texas |
United States | Albireo Investigative Site | Lynchburg | Virginia |
United States | Albireo Investigative Site | Marlton | New Jersey |
United States | Albireo Investigative Site | Mission | Kansas |
United States | Albireo Investigative Site | Monroe | Louisiana |
United States | Albireo Investigative Site | Ogden | Utah |
United States | Albireo Investigative Site | Oklahoma City | Oklahoma |
United States | Albireo Investigative Site | Overland Park | Kansas |
United States | Albireo Investigative Site | Peoria | Illinois |
United States | Albireo Investigative Site | Phoenix | Arizona |
United States | Albireo Investigative Site | Salt Lake City | Utah |
United States | Albireo Investigative Site | San Antonio | Texas |
United States | Albireo Investigative Site | San Diego | California |
United States | Albireo Investigative Site | Shreveport | Louisiana |
United States | Albireo Investigative Site | Statesville | North Carolina |
United States | Albireo Investigative Site | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Albireo |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in frequency of spontaneous bowel movements | Weekly | No | |
Secondary | Responder analyses for complete spontaneous bowel movements | weekly and for duration of study | No | |
Secondary | Time to first bowel movement | First week | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 |